Clinical Trial Detail

NCT ID NCT03201458
Title Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

cholangiocarcinoma

Therapies

Atezolizumab

Atezolizumab + Cobimetinib

Age Groups: adult senior

No variant requirements are available.